Pleurisy
ICD-10 R09.1 · ICD-11 MD31.1

Treatment of Pleurisy in Suspected Drug-Induced Pleuritis or Drug-Induced Lupus Pleuritis

Pleurisy that arises in the setting of suspected drug-induced pleuritis or drug-induced lupus pleuritis represents a distinct clinical scenario requiring a targeted management approach that differs from other causes of pleural inflammation.

Clinical Scenario

This protocol applies when pleurisy is encountered in a patient where drug-induced pleuritis or drug-induced lupus pleuritis is the suspected underlying aetiology.

Management Approach

Management is directed at the suspected precipitating cause. A specific intervention targeting the identified agent is central to the approach.

The complete evaluation criteria, management steps, and follow-up algorithm are available in the full protocol below.

Instant Access to Structured Evidence-Based Regimens

References

If a patient has suspected drug-induced pleuritis or drug-induced lupus pleuritis, the causal agent should be discontinued.

View source ↗